The potential role of myocardial serotonin receptor 2B expression in canine dilated cardiomyopathy

Veterinary Journal

Volumn 199, Issue 3, 2014, Pages 406-412

  Fonfara, Sonja ^a   Hetzel, Udo ^a   Oyama, Mark A ^b   Kipar, Anja ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cardiac disease; Dilated cardiomyopathy; Heart failure; Myocardial remodelling; Serotonin

Indexed keywords

CYTOKINE; MATRIX METALLOPROTEINASE; MESSENGER RNA; SEROTONIN 2B RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOG; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; MALE; MOLECULAR PATHOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; ANIMAL; DOG DISEASE; GENE EXPRESSION REGULATION; GENETICS; HEART ATRIUM; HEART MUSCLE; HEART VENTRICLE; METABOLISM; VETERINARY;

ANIMALS; CARDIOMYOPATHY, DILATED; CYTOKINES; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION; HEART ATRIA; HEART VENTRICLES; MALE; METALLOPROTEASES; MYOCARDIUM; POLYMERASE CHAIN REACTION; RECEPTOR, SEROTONIN, 5-HT2B; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84897438508     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2013.12.003     Document Type: Article

References (39)

1. Anker S.D., von Haehling S. Inflammatory mediators in chronic heart failure: An overview. Heart 2004, 90:464-470.
2. Arndt J.W., Reynolds C.A., Singletary G.E., Connolly J.M., Levy R.J., Oyama M.A. Serum serotonin concentrations in dogs with degenerative mitral valve disease. Journal of Veterinary Internal Medicine 2009, 23:1208-1213.
3. Aupperle H., Marz I., Thielebein J., Schoon H.A. Expression of transforming growth factor-beta1, -beta2 and -beta3 in normal and diseased canine mitral valves. Journal of Comparative Pathology 2008, 139:97-107.
4. Brundel B.J., Melnyk P., Rivard L., Nattel S. The pathology of atrial fibrillation in dogs. Journal of Veterinary Cardiology 2005, 7:121-129.
5. Charniot J.C., Vignat N., Monsuez J.J., Kidouche R., Avramova B., Artigou J.Y., Albertini J.P. Cardiogenic shock associated with reversible dilated cardiomyopathy during therapy with regular doses of venlafaxine. American Journal of Emergency Medicine 2010, 28:e251-e255.
6. Choi D.S., Maroteaux L. Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain. FEBS Letters 1996, 391:45-51.
7. Disatian S., Orton E.C. Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease. Journal of Heart Valve Disease 2009, 18:44-51.
8. Elangbam C.S., Job L.E., Zadrozny L.M., Barton J.C., Yoon L.W., Gates L.D., Slocum N. 5-Hydroxytryptamine (5HT)-induced valvulopathy: Compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats. Experimental and Toxicologic Pathology 2008, 60:253-262.
9. Elangbam C.S., Lightfoot R.M., Yoon L.W., Creech D.R., Geske R.S., Crumbley C.W., Gates L.D., Wall H.G. 5-Hydroxytryptamine (5HT) receptors in the heart valves of cynomolgus monkeys and Sprague-Dawley rats. Journal of Histochemistry Cytochemistry 2005, 53:671-677.
10. Fitzgerald L.W., Burn T.C., Brown B.S., Patterson J.P., Corjay M.H., Valentine P.A., Sun J.H., Link J.R., Abbaszade I., Hollis J.M., et al. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Molecular Pharmacology 2000, 57:75-81.
11. Fonfara S., Tew S.R., Cripps P., Dukes-McEwan J., Clegg P.D. Increased blood mRNA expression of inflammatory and anti-fibrotic markers in dogs with congestive heart failure. Research in Veterinary Science 2011, 93:879-885.
12. Fonfara S., Hetzel U., Tew S., Cripps P., Dukes-McEwan J., Clegg P. Myocardial cytokine expression in dogs with systemic and naturally occurring cardiac diseases. American Journal of Veterinary Research 2013, 74:408-416.
13. Fonfara S., Hetzel U., Tew S., Cripps P., Dukes-McEwan J., Clegg P. Myocardial matrix metalloproteinases, their inhibitors, and lysyl oxidase in myocardial samples from dogs with end-stage systemic and cardiac diseases. American Journal of Veterinary Research 2013, 74:216-223.
14. Huntgeburth M., Tiemann K., Shahverdyan R., Schluter K.D., Schreckenberg R., Gross M.L., Modersheim S., Caglayan E., Muller-Ehmsen J., Ghanem A., et al. Transforming growth factor beta(1) oppositely regulates the hypertrophic and contractile response to beta-adrenergic stimulation in the heart. PLoS ONE 2011, 6:e26628.
15. Hutcheson J.D., Setola V., Roth B.L., Merryman W.D. Serotonin receptors and heart valve disease - It was meant 2B. Pharmacology and Therapeutics 2011, 132:146-157.
16. Jaffre F., Bonnin P., Callebert J., Debbabi H., Setola V., Doly S., Monassier L., Mettauer B., Blaxall B.C., Launay J.M., Maroteaux L. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy. Circulation Research 2009, 104:113-123.
17. Jaffre F., Callebert J., Sarre A., Etienne N., Nebigil C.G., Launay J.M., Maroteaux L., Monassier L. Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: Control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts. Circulation 2004, 110:969-974.
18. Jonnakuty C., Gragnoli C. What do we know about serotonin?. Journal of Cellular Physiology 2008, 217:301-306.
19. Kaumann A.J., Levy F.O. 5-Hydroxytryptamine receptors in the human cardiovascular system. Pharmacology and Therapeutics 2006, 111:674-706.
20. Lacerda C.M., Kisiday J., Johnson B., Orton E.C. Local serotonin mediates cyclic strain-induced phenotype transformation, matrix degradation, and glycosaminoglycan synthesis in cultured sheep mitral valves. American Journal of Physiology. Heart and Circulatory Physiology 2012, 302:H1983-H1990.
21. Lacerda C.M., Maclea H.B., Kisiday J.D., Orton E.C. Static and cyclic tensile strain induce myxomatous effector proteins and serotonin in canine mitral valves. Journal of Veterinary Cardiology 2012, 14:223-230.
22. Liang Y.J., Lai L.P., Wang B.W., Juang S.J., Chang C.M., Leu J.G., Shyu K.G. Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-kappaB in cardiomyocytes. Cardiovascular Research 2006, 72:303-312.
23. Martin M.W., Stafford Johnson M.J., Celona B. Canine dilated cardiomyopathy: A retrospective study of signalment, presentation and clinical findings in 369 cases. Journal of Small Animal Practice 2009, 50:23-29.
24. Nebigil C.G., Hickel P., Messaddeq N., Vonesch J.L., Douchet M.P., Monassier L., Gyorgy K., Matz R., Andriantsitohaina R., Manivet, et al. Ablation of serotonin 5-HT(2B) receptors in mice leads to abnormal cardiac structure and function. Circulation 2001, 103:2973-2979.
25. Nebigil C.G., Jaffre F., Messaddeq N., Hickel P., Monassier L., Launay J.M., Maroteaux L. Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy. Circulation 2003, 107:3223-3229.
26. Nebigil C.G., Maroteaux L. Functional consequence of serotonin/5-HT2B receptor signaling in heart: Role of mitochondria in transition between hypertrophy and heart failure?. Circulation 2003, 108:902-908.
27. Orton E.C., Lacerda C.M., Maclea H.B. Signaling pathways in mitral valve degeneration. Journal of Veterinary Cardiology 2012, 14:7-17.
28. Oyama M.A., Chittur S.V. Genomic expression patterns of mitral valve tissues from dogs with degenerative mitral valve disease. American Journal of Veterinary Research 2006, 67:1307-1318.
29. Oyama M.A., Chittur S.V., Reynolds C.A. Decreased triadin and increased calstabin2 expression in Great Danes with dilated cardiomyopathy. Journal of Veterinary Internal Medicine 2009, 23:1014-1019.
30. Oyama M.A., Levy R.J. Insights into serotonin signaling mechanisms associated with canine degenerative mitral valve disease. Journal of Veterinary Internal Medicine 2010, 24:27-36.
31. Ramos-Mondragon R., Vega A.V., Avila G. Long-term modulation of Na+ and K+ channels by TGF-beta1 in neonatal rat cardiac myocytes. Pflugers Archives 2011, 461:235-247.
32. Rothman R.B., Baumann M.H., Savage J.E., Rauser L., McBride A., Hufeisen S.J., Roth B.L. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 2000, 102:2836-2841.
33. Schultz J., Witt S.A., Glascock B.J., Nieman M.L., Reiser P.J., Nix S.L., Kimball T.R., Doetschman T. TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. Journal of Clinical Investigations 2002, 109:787-796.
34. Scruggs S.M., Disatian S., Orton E.C. Serotonin transmembrane transporter is down-regulated in late-stage canine degenerative mitral valve disease. Journal of Veterinary Cardiology 2010, 12:163-169.
35. Sheline Y.I., Freedland K.E., Carney R.M. How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease?. American Journal of Medicine 1997, 102:54-59.
36. Shyu K.G. Serotonin 5-HT2B receptor in cardiac fibroblast contributes to cardiac hypertrophy: A new therapeutic target for heart failure?. Circulation Research 2009, 104:1-3.
37. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function. Physiology Reviews 2007, 87:1285-1342.
38. Strickland K.N. Pathophysiology and therapy of heart failure. Manual of Canine and Feline Cardiology 2008, 288-314. Saunders Elsevier, St. Louis. L.P. Tilley, F.W.K. Smith, M.A. Oyama, M.M. Sleeper (Eds.).
39. Yabanoglu S., Akkiki M., Seguelas M.H., Mialet-Perez J., Parini A., Pizzinat N. Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors. Journal of Molecular and Cellular Cardiology 2009, 46:518-525.